Kombucha ERP

Has the method author addressed Final Action requirements as noted by the ERP Report, if any?

The final actions requirements are not met.

The number collaborative study participants (4) does not meet AOAC Validation Guidelines (Appendix F). As per AOAC Appendix F; for quantitative methods, recruit 10–12 collaborators; must have eight valid data sets; two blind duplicate replicates at five concentrations for each analyte/matrix combination to each collaborator. Number of samples used in the collaborative study is insufficient to represent the Kombucha products. Eight sampes were used in the SLV study whereas only six samples were included in the MLT study.

8. RECOMMENDED CHANGES (If any)

Are there any recommended changes to the AOAC First Action method as written?

No changes to the AOAC First Action method 2016.12 as published

9. END USER FEEDBACK:

Document positive and negative feedback from users of the method during the trial period. Feedback from users demonstrating method ruggedness should be documented. Assess the future availability of vital equipment, reference materials, and supplies.

Have you run this method? If yes, please provide details (pros, cons, general feedback) of your experience running this method. To your knowledge, has this method received any awards or recognition?

No feedback available to me at the time of the review.

No

FINAL ACTION RECOMMENDATION

Do you recommend this method be adopted as a Final Action Official Method of Analysis and published by AOAC INTERNATIONAL? Please specify rationale for your answer.

Not recommended for Final Action at this stage. I would like to see more labs / data and samples in the collaborative study before being considered for Final Action status